Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Yan Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4535-8199; OpenAlex author ID A5101553054. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Glycolysis in the progression of pancreatic cancer. Last author PMID 35261808↗
  2. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2016.1258504↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuan Yang · 1 shared paper, 2022 · strength 0.20
  2. Xinyao Chang · 1 shared paper, 2022 · strength 0.20
  3. Xiongfei Xu · 1 shared paper, 2017 · strength 0.06
  4. Gang Y Jin · 1 shared paper, 2017 · strength 0.06
  5. Chenyan Zhao · 1 shared paper, 2017 · strength 0.06
  6. Min Shi · 1 shared paper, 2017 · strength 0.06
  7. Biao Yang · 1 shared paper, 2017 · strength 0.06
  8. Jing Zhang · 1 shared paper, 2017 · strength 0.06
  9. Ying Chen · 1 shared paper, 2017 · strength 0.06
  10. Shiwei Guo · 1 shared paper, 2017 · strength 0.06
  11. Minghua Zhu · 1 shared paper, 2017 · strength 0.06
  12. Guiling Ding · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.